Current Liabilities Değişiklik Tarih
AbbVie USD 34.77B 2.53B 2023-09
Abbott USD 14.35B 180M 2023-06
Amgen USD 18.39B 1.44B 2023-12
AstraZeneca USD 28.59B 2.21B 2023-09
Baxter International USD 6.5B 294M 2023-12
Bayer EUR 33.08B 894M 2023-09
Becton, Dickinson and Co. USD 7.54B 899M 2023-12
Biogen USD 3.43B 1.59B 2023-12
Boston Scientific USD 4.58B 17M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
CONMED USD 376.32M 23.15M 2023-09
Cooper Companies USD 964.9M 4.1M 2023-12
Dexcom USD 1.56B 122.6M 2023-12
Edwards Lifesciences USD 1.2B 43.5M 2023-12
Eli Lilly USD 22B 3.08B 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
Globus Medical USD 392.35M 36.38M 2023-12
Hologic USD 899M 308.3M 2023-12
Insulet USD 451.2M 200K 2023-12
Integra LifeSciences USD 306.98M 48.73M 2023-12
Intuitive Surgical USD 2.04B 367.8M 2023-12
J&J USD 44.37B 9.8B 2023-09
Merck USD 23.09B 300M 2023-09
Merit Medical Systems USD 203.56M 16.43M 2023-12
Pfizer USD 31.14B 3.51B 2023-09
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Roche Holding CHF 26.21B 1.03B 2023-06
Stryker USD 7.89B 432M 2023-12
Tandem Diabetes Care USD 195.26M 8.15M 2023-12
Teva Pharmaceutical Industries USD 11.39B 449M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09
Zimmer Biomet Holdings USD 2.86B 786M 2023-12
Zoetis USD 1.89B 281M 2023-12



J&J Kısa Vadeli Yükümlülükler - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Mar 2024.